imidazolium NCH), 70.7 (cage C), 29.3 (CH(CH3)2), 25.7, 22.4
(CH(CH3)2), the imidazolium NCN carbon was not observed.
11B NMR (CD2Cl2): δ 23.5 (d, J = 90 Hz, 1B), −2.6 (d, J =
128 Hz, 2B), −7.3 (d, J = 141 Hz, 2B), −9.2 (d, J = 179 Hz,
1B), −9.8 (s, 1B), −17.7 (d, J = 141 Hz, 1B), −20.1 (d, J =
115 Hz, 2B). IR (KBr, cm−1): νBH 2580 (vs). HRMS: m/z calcd
for C35H52B10N2 [M − H]+: 607.5050. Found: 607.5060.
J = 7.8 Hz, 4H, C6H3), 7.13 (s, 2H, imidazolium NCH), 5.47 (s,
2H, CH2CHvCHCH2), 2.64 (m, 4H, CH(CH3)2), 2.45 (d, J =
16.9 Hz, 2H, CH2CHvCHCH2), 2.33 (d, J = 16.9 Hz, 2H,
CH2CHvCHCH2), 1.34 (d, J = 6.8 Hz, 12H, CH(CH3)2),
1.14 (d, J = 6.8 Hz, 12H, CH(CH3)2). 13C{1H} NMR (CD2Cl2):
δ 145.9, 132.8, 131.3, 124.3, 123.4, 123.1 (C6H3, imidazolium
NCH
&
CH2CHvCHCH2), 34.8 (CH2CH2vCH2CH2),
29.4 (CH(CH3)2), 25.9, 22.0 (CH(CH3)2), the imidazolium NCN
and cage C were not observed. 11B NMR (CD2Cl2): δ 15.9 (d,
J = 115 Hz, 1B), −1.1 (d, J = 128 Hz, 2B), −7.6 (d, J = 128 Hz,
1B), −13.1 (d, J = 141 Hz, 2B), −17.6 (d, J = 115 Hz, 4B). IR
(KBr, cm−1): νBH 2533 (vs). HRMS: m/z calcd for C33H52B10N2
[M − H]+: 583.5050. Found: 583.5045.
Preparation of 6-I-μ-9,10,11-[2′-{1′,3′-[2′′,6′′-iPr2(C6H3)]2-
1′,3′-N2C3H2}]BH-7,8-C2B9H11 (3g). This complex was prepared
as colorless crystals from 9-iodo-o-carborane (27 mg, 0.1 mol)
and 2 (78 mg, 0.2 mmol) in THF using the same procedure as
reported for 3a: yield 60 mg (91%). X-Ray-quality crystals were
grown from a saturated diethyl ether solution at room tempera-
1
ture. H NMR (CD2Cl2): δ 7.55 (t, J = 7.8 Hz, 2H, C6H3), 7.34
Preparation
of
7,8-[o-C6H4(CH2)2]-μ-9,10,11-[2′-{1′,3′-
(3j). This
(m, 4H, C6H3), 7.20 (s, 2H, imidazolium NCH), 3.09 (s, 1H,
cage CH), 2.81 (s, 1H, cage CH), 2.68 (m, 2H, CH(CH3)2), 2.53
(m, 2H, CH(CH3)2), 1.40 (d, J = 7.2 Hz, 6H, CH(CH3)2), 1.38
(d, J = 7.8 Hz, 6H, CH(CH3)2), 1.18 (d, J = 6.8 Hz, 12H, CH-
(CH3)2). 13C{1H} NMR (CD2Cl2): δ 146.0, 145.7, 132.3, 131.5,
124.6, 124.5, 123.8 (C6H3 & imidazolium NCH), 29.5, 29.4
(CH(CH3)2), 25.9, 25.8, 22.9, 22.1 (CH(CH3)2), the imidazolium
NCN and cage C atoms were not observed. 11B NMR (CD2Cl2):
δ 23.8 (d, J = 90 Hz, 1B), −1.5 (d, J = 141 Hz, 1B), −3.6 (d,
J = 179 Hz, 1B), −5.0 (d, J = 141 Hz, 1B), −6.0 (d, J = 128 Hz,
1B), −15.9 (d, J = 141 Hz, 1B), −17.1 (d, J = 154 Hz, 2B),
−19.2 (d, J = 102 Hz, 1B), −19.8 (s, 1B). IR (KBr, cm−1): νBH
2574 (vs). HRMS: m/z calcd for C29H47B10IN2 [M − H]+:
657.3703. Found: 657.3706.
[2′′,6′′-iPr2(C6H3)]2-1′,3′-N2C3H2}]BH-7,8-C2B9H11
complex was prepared as light-yellow crystals from 1,2-
[o-C6H4(CH2)2]-1,2-C2B10H10 (24 mg, 0.1 mol) and 2 (78 mg,
0.2 mmol) in THF using the same procedure as reported for 3a:
yield 57 mg (90%). X-Ray-quality crystals were grown from a
1
saturated diethyl ether solution at room temperature. H NMR
(CD2Cl2): δ 7.57 (t, J = 7.8 Hz, 2H, C6H3), 7.34 (d, J = 7.8 Hz,
4H, C6H3), 7.16 (s, 2H, imidazolium NCH), 7.05 (m, 2H,
o-C6H4(CH2)2), 6.85 (m, 2H, o-C6H4(CH2)2), 3.20 (d, J =
16.5 Hz, 2H, o-C6H4(CH2)2), 2.84 (d, J = 16.5 Hz, 2H,
o-C6H4(CH2)2), 2.68 (m, 4H, CH(CH3)2), 1.32 (d, J = 6.8 Hz,
12H, CH(CH3)2), 1.14 (d, J = 6.8 Hz, 12H, CH(CH3)2). 13C
{1H} NMR (CD2Cl2): δ 145.8, 135.2, 132.8, 131.3, 130.5,
127.1, 126.3, 124.4, 123.6 (C6H3, imidazolium NCH &
o-C6H4(CH2)2), 38.9 (o-C6H4(CH2)2), 29.4 (CH(CH3)2), 25.9,
22.0 (CH(CH3)2), the imidazolium NCN and cage C were not
observed. 11B NMR (CD2Cl2): δ 17.8 (d, J = 90 Hz, 1B), 1.2 (d,
J = 128 Hz, 2B), −6.5 (d, J = 115 Hz, 1B), −11.2 (d, J =
141 Hz, 2B), −17.6 (d, J = 128 Hz, 4B). IR (KBr, cm−1): νBH
2527 (vs). HRMS: m/z calcd for C37H54B10N2 [M − H]+:
633.5224. Found: 633.5233.
Preparation of 7,8-(CH2)3-μ-9,10,11-[2′-{1′,3′-[2′′,6′′-iPr2(C6H3)]2-
1′,3′-N2C3H2}]BH-7,8-C2B9H11 (3h). This complex was prepared
as colorless crystals from 1,2-(CH2)3-1,2-C2B10H10 (18 mg,
0.1 mol) and 2 (78 mg, 0.2 mmol) in THF using the same pro-
cedure as reported for 3a: yield 50 mg (88%). X-Ray-quality
crystals were grown from a saturated diethyl ether solution at
room temperature. 1H NMR (CD2Cl2): δ 7.53 (t, J = 7.8 Hz, 2H,
C6H3), 7.32 (d, J = 8.0 Hz, 4H, C6H3), 7.15 (s, 2H, imidazolium
NCH), 2.67 (m, 4H, CH(CH3)2), 1.97 (m, 2H, CH2), 1.86 (m,
2H, CH2), 1.66 (m, 1H, CH2), 1.36 (d, J = 6.8 Hz, 12H,
CH(CH3)2), 1.28 (m, 1H, CH2), 1.15 (d, J = 6.8 Hz, 12H,
CH(CH3)2). 13C{1H} NMR (CD2Cl2): δ 145.8, 132.8, 131.2,
124.3, 123.6 (C6H3 & imidazolium NCH), 67.9 (cage C), 36.3
(CH2CH2CH2), 29.4 (CH(CH3)2), 26.9 (CH2CH2CH2), 25.8,
25.7, 21.9 (CH(CH3)2), the imidazolium NCN carbon was not
observed. 11B NMR (CD2Cl2): δ 19.0 (d, J = 102 Hz, 1B),
−1.35 (d, J = 141 Hz, 2B), −5.7 (d, J = 115 Hz, 1B), −13.2 (d,
J = 141 Hz, 2B), −16.7 (d, J = 141 Hz, 1B), −18.1 (d, J =
192 Hz, 1B), −19.3 (d, J = 128 Hz, 2B). IR (KBr, cm−1): νBH
2542 (vs). HRMS: m/z calcd for C32H52B10N2 [M − H]+:
571.5050. Found: 571.5043.
Preparation
of
[1′,3′-{2′′,6′′-iPr2(C6H3)}2-1′,3′-N2C3H3]-
[C2B9H12] (4a). H2O (0.1 mL) was added to a stirring solution
of 3a (53 mg, 0.1 mmol) in acetone (10 mL) at room tempera-
ture, and the mixture was stirred for 2 d. The solvent was
removed in vacuo and the resulting light-green oil was extracted
by diethyl ether (5 mL × 3). The ether solutions were combined
and concentrated to 10 mL. Complex 4a was obtained as color-
less crystals after this solution stood at room temperature over-
night (42 mg, 81%). 1H NMR (CD3COCD3): δ 9.82 (s, 1H,
imidazolium NCHN), 8.45 (s, 2H, NCHvCHN), 7.71 (t, J =
7.8 Hz, 2H, C6H3), 7.55 (d, J = 7.6 Hz, 4H, C6H3), 2.60 (m, 4H,
CH(CH3)2), 1.31 (d, J = 6.8 Hz, 12H, CH(CH3)2), 1.26 (d, J =
6.8 Hz, 12H, CH(CH3)2). 13C{1H} NMR (CD3COCD3): δ
146.1, 139.5, 133.1, 131.1, 127.4, 125.7 (C6H3, NCHN &
NCHvCHN), 29.9 (CH(CH3)2), 24.6, 23.8 (CH(CH3)2), the
cage C atoms were not observed. 11B NMR (CD3COCD3):
δ −10.0 (d, J = 128 Hz, 2B), −15.9 (d, J = 115 Hz, 2B), −16.7
(d, J = 128 Hz, 1B), −21.4 (d, J = 154 Hz, 2B), −32.3 (d, J =
128 Hz, 1B), −36.9 (d, J = 141 Hz, 1B). IR (KBr, cm−1): νBH
2529 (vs). Anal. calcd for C29H49B9N2: C, 66.60; H, 9.40; N,
5.36. Found: C, 66.01; H, 9.33; N, 4.99.
Preparation of 7,8-(CH2CHvCHCH2)-μ-9,10,11-[2′-{1′,3′-
[2′′,6′′-iPr2(C6H3)]2-1′,3′-N2C3H2}]BH-7,8-C2B9H11
(3i). This
complex was prepared as colorless crystals from 1,2-
(CH2CHvCHCH2)-1,2-C2B10H10 (20 mg, 0.1 mol) and 2
(78 mg, 0.2 mmol) in THF using the same procedure as reported
for 3a: yield 51 mg (86%). X-Ray-quality crystals were grown
from a saturated diethyl ether solution at room temperature.
1H NMR (CD2Cl2): δ 7.54 (t, J = 7.8 Hz, 2H, C6H3), 7.32 (d,
12912 | Dalton Trans., 2012, 41, 12907–12914
This journal is © The Royal Society of Chemistry 2012